MR. MAREK A STAWISKI MD NPI 1679573331

NPI Details

MR. Marek A Stawiski, MD is a dermatopathology dermatology in Grand Rapids, MI with 56 years of experience. The provider is a dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes. MR. Marek A Stawiski, MD NPI is 1679573331. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Graduation Year:1970

The provider's business location address is:

833 MICHIGAN ST NE
SUITE 102
GRAND RAPIDS, MI
ZIP 49503-523
Phone: (616) 459-8209
Fax: (616) 459-0313

The NPI 1679573331 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Biopsy of ear (HCPCS:69100)
• Removal of skin tag, 1-15 skin tags (HCPCS:11200)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/26/2005 and was last updated on 1/22/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.